In the second quarter of 2025 Coulter Partners drove global executive search for a wide range of life sciences, health, and technology organizations. 

We successfully placed executives for venture capital & private equity-backed firms, alongside large-cap, mid-cap, and public companies, filling critical roles across diverse disciplines worldwide.

CEO/ C-suite/ Board

• CEO, ADC oncology company (VC-backed), UK
• CEO, Immuno-oncology therapeutics (Publicly listed), US
• CEO, Sustainable chemical biomanufacturing (VC-backed), Sweden
• CEO, Exosome technologies (VC-backed), Italy
• Chief Commercial Officer, Cell therapy biotech (Publicly listed), US
• Chief Business Officer/ Chief Financial Officer, Epigenetics (VC-backed), US
• Chief Financial Officer, Small molecule therapeutics (VC-backed), US
• Chair, Healthtech (VC-backed), US
• Board Director, Specialized healthcare manufacturing (Publicly listed), Australia
• Board Director, Obesity therapeutics (Publicly listed), US
• Board Director, Oncology therapeutics (VC-backed), Australia
• Board Director, Antibody platform technologies (VC-backed), Canada

Commercial/Functional/Strategic

• VP, Sales & Marketing Europe, Surgical technologies (Privately owned), Germany
• VP, Strategy (Diagnostics), Genetic testing (Publicly listed), US
• VP, Global Marketing, CDMO (Large operating subsidiary), US
• Country Chief Financial Officer, Healthcare services (PE-backed), Germany
• General Manager, Europe, Cell therapy biotech (Publicly listed), US
• General Manager & Alliance Lead, International Markets, Biopharmaceuticals (Publicly listed), US
• Global IT Director, Specialty pharma (Family owned), Italy
• Corporate HR Director, Hormonal health (Family owned), France
• Senior Director, Commercial Operations, Medical devices (Publicly listed), Netherlands

R&D/Medical/Technical

• Chief Scientific Officer, AI-enabled CNS therapeutics (VC-backed), US
• Chief Technology Officer, Neuromodulation devices (VC-backed), UK
• VP, Head Translational Development, Genomic technologies (VC-backed), Spain
• VP, Combination Product Quality & Safety, Multinational biotech (Publicly listed), US
• AVP, Technical Operations, Life-extending technologies (Publicly listed), US
• Head Clinical Safety, Specialty pharma (Privately owned), France
• Global Head Toxicology Services, Laboratory & consulting services (PE-backed), Germany
• Global Medical Affairs Director/s, Medical apparatus leader (Publicly listed), France

Investor/ Not for Profit/ Accelerator/ Other

• Senior General Partner, Science & research VC, Germany
• Venture Partner, Life sciences investor, Denmark
• Investment Professional, Life sciences investor, US
• Director of Venture Creation, Leading university, UK